In a retrospective, multicenter study, a risk score based on PIVKA-II and AFP could reflect tumor aggressiveness, and a high score of greater than 68 was determined as an independent prognostic factor of recurrence-free survival after RFA (HR=4.84; 95% CI: 1.83–35.68; P=0.008)32. This evidence concerns the gene AFP and neoplasm.